User:Doron Calo/Opko Biologics: Difference between revisions
Content deleted Content added
Doron Calo (talk | contribs) No edit summary |
Doron Calo (talk | contribs) ←Replaced content with '{{Userspace draft|source=ArticleWizard|date=August 2015}}' |
||
| Line 1: | Line 1: | ||
{{Userspace draft|source=ArticleWizard|date=August 2015}} |
{{Userspace draft|source=ArticleWizard|date=August 2015}} |
||
'''OPKO Biologics''' (formerly Prolor Biotech) is a clinical-stage company that developes long-acting, [[bio-better]] versions of therapeutic proteins and peptides, using [[CTP]] and reversible [[PEGylation]] technologies. OPKO biologics is a subsidiary of [[OPKO Health]]. |
|||
== References == |
|||
<!--- See http://en.wikipedia.org/wiki/Wikipedia:Footnotes on how to create references using <ref></ref> tags, these references will then appear here automatically --> |
|||
{{Reflist}} |
|||
== External links == |
|||
* [http://www.example.com www.example.com] |
|||
<!--- Categories ---> |
|||
[[Category:Articles created via the Article Wizard]] |
|||
Latest revision as of 14:09, 5 August 2015
 | This is not a Wikipedia article: It is an individual user's work-in-progress page, and may be incomplete and/or unreliable. For guidance on developing this draft, see Wikipedia:So you made a userspace draft. Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL |